Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in women. This is mainly due to relapse and reoccurrence of tumor. The primary reason for cancer relapse is the development of multidrug resistance (MDR) hampering the treatment and prognosis. MDR can occur...
Main Authors: | Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla, Dhananjay Pal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4673 |
Similar Items
-
Multifunctional polymeric micelles for delivery of drugs and siRNA
by: Aditi M. Jhaveri, et al.
Published: (2014-04-01) -
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
by: Kajal Rajput, et al.
Published: (2022-09-01) -
VEGF Overexpression Significantly Increases Nanoparticle-Mediated siRNA Delivery and Target-Gene Downregulation
by: Shanshan Tan, et al.
Published: (2022-06-01) -
Specific siRNA Targeting Receptor for Advanced Glycation End Products (RAGE) Decreases Proliferation in Human Breast Cancer Cell Lines
by: Sheng Liu, et al.
Published: (2013-04-01) -
Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells
by: Chia-Che Chang, et al.
Published: (2021-11-01)